A detailed history of Quarry LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Quarry LP holds 11,500 shares of BBIO stock, worth $524,630. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,500
Holding current value
$524,630
% of portfolio
0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$28.12 - $37.59 $323,380 - $432,285
11,500 New
11,500 $398 Million
Q3 2024

Nov 14, 2024

BUY
$23.91 - $31.3 $59,775 - $78,250
2,500 Added 33.33%
10,000 $255 Million
Q2 2024

Aug 14, 2024

BUY
$23.0 - $31.04 $36,800 - $49,664
1,600 Added 27.12%
7,500 $190 Million
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $127,177 - $188,092
4,650 Added 372.0%
5,900 $182 Million
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $30,025 - $54,862
1,250 New
1,250 $50.5 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $6.76B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.